Immunome News and Activities
Presence
Immunome is a biotechnology company that develops antibody-based medicines and targeted cancer treatments. Its products and research services support patients, healthcare providers, and biopharmaceutical partners in oncology and infectious disease markets.
Immunome products and services overview:
- Cancer therapies
- Antibody medicines
- Targeted therapeutics
- Drug discovery
- Clinical development
Revenue: ~$20 million
Employees: 300
Headquarters: Bothell, United States (USA)
Immunome is one of the...
Immunome is a company listed under the stock ticker IMNM (US).
Executives
View the org chart displaying its 29 main executives
Most searched biographies at Immunome
- Clay Siegall, Chairman of the Board, President & Chief Executive O...
- Philip Wagenheim, Director
- Isaac Barchas, Lead Independent Director and Director
Popular executive movements at Immunome
- Erik Nelson, Head, Information Technology, has left the company (posted on April 24 2026).
Create your alert
to follow the executive moves at Immunome.
Biotechnology
Immunome has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).
Popular M&A news in Biotechnology
- Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
- RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
- Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
Popular contacts in Biotechnology
News
Press releases by Immunome
Social media about Immunome
- Immunome on Wikipedia, Google News & Yahoo Finance
- Immunome on LinkedIn, X (Twitter) & YouTube
